<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> transfer from solid-phase bound <z:chebi fb="17" ids="39025">HDL</z:chebi> to endogenous plasma <z:chebi fb="17" ids="39025">HDL</z:chebi> or <z:chebi fb="1" ids="39027">VLDL</z:chebi>/<z:chebi fb="15" ids="39026">LDL</z:chebi> was determined in 50 patients with <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disorders</z:e> of <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism and 27 normolipidemic subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Transfer to the plasma <z:chebi fb="17" ids="39025">HDL</z:chebi> pool was significantly reduced in familial <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo>, familial <z:hpo ids='HP_0008356'>combined hyperlipidemia</z:hpo>, <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> and <z:e sem="disease" ids="C0020479" disease_type="Disease or Syndrome" abbrv="">dysbetalipoproteinemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Subfractionation of <z:chebi fb="17" ids="39025">HDL</z:chebi> revealed that the <z:chebi fb="23" ids="18059">lipid</z:chebi> transfer to HDL3 was significantly reduced in <z:hpo ids='HP_0000001'>all</z:hpo> patient groups while transfer to HDL2 was increased in those with <z:e sem="disease" ids="C0020479" disease_type="Disease or Syndrome" abbrv="">dysbetalipoproteinemia</z:e> and familial <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Transfer to <z:chebi fb="15" ids="39026">LDL</z:chebi> and <z:chebi fb="1" ids="39027">VLDL</z:chebi> was increased only in patients with <z:e sem="disease" ids="C0020479" disease_type="Disease or Syndrome" abbrv="">dysbetalipoproteinemia</z:e> and <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Reduced transfer to <z:chebi fb="17" ids="39025">HDL</z:chebi> occurred in samples with altered <z:chebi fb="17" ids="39025">HDL</z:chebi> composition; particularly where <z:chebi fb="17" ids="39025">HDL</z:chebi>-<z:chebi fb="0" ids="17855">triglyceride</z:chebi> was significantly increased and <z:chebi fb="17" ids="39025">HDL</z:chebi>-cholesteryl <z:chebi fb="21" ids="35701">esters</z:chebi> were reduced </plain></SENT>
<SENT sid="5" pm="."><plain>Transfer of cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> to HDL3 was significantly decreased in patients with <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings indicate that impaired interaction of cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> transfer protein with the HDL3 pool may contribute to the risk of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> in patients with specific plasma <z:chebi fb="23" ids="18059">lipid</z:chebi> abnormalities </plain></SENT>
</text></document>